Federal award
EMERGENT TRAVEL HEALTH INC.
W81XWH16C0127
ContractSBIR/STTR SR3
Obligated and Ceiling
- Obligated (net)
- $3,161,941.10
- Ceiling (potential value, not spending)
- $3,161,941.10
- Current value
- $3,161,941.10
- Gross positive obligations
- $3,375,000.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- EMERGENT TRAVEL HEALTH INC. · CXEUFMM1FXY8
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- EMERGENT BIOSOLUTIONS INC. · M7ZHZ4P2MDG4
- Awarding agency
- Department of War · sub-agency 2100 · office W81XWH
- Funding agency
- Department of War · sub-agency 2100
- Product or service (PSC)
- AN91 · R&D- MEDICAL: OTHER (BASIC RESEARCH)
- Industry (NAICS)
- 325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
- PIID
- W81XWH16C0127
- Award type code
- D
- Actions
- 12 · Aug 25, 2016 to Jan 27, 2020
- Why it is listed
- gross positive obligations of $100k or more (contracts); SBIR/STTR award
Action History12
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jan 27, 2020 | FY2020 | P00011 | V | $0.00 | — |
| Mar 26, 2019 | FY2019 | P00010 | F | −$213,058.90 | — |
| Dec 14, 2018 | FY2019 | P00009 | M | $0.00 | — |
| Jul 31, 2018 | FY2018 | P00008 | M | $0.00 | — |
| Jun 29, 2018 | FY2018 | P00007 | M | $0.00 | — |
| Mar 19, 2018 | FY2018 | P00006 | M | $0.00 | — |
| Dec 14, 2017 | FY2018 | P00005 | M | $600,000.00 | — |
| Sep 23, 2017 | FY2017 | P00004 | C | $175,000.00 | — |
| May 18, 2017 | FY2017 | P00003 | C | $365,000.00 | — |
| Apr 27, 2017 | FY2017 | P00002 | C | $35,000.00 | — |
| Feb 15, 2017 | FY2017 | P00001 | C | $600,000.00 | — |
| Aug 25, 2016 | FY2016 | 0 | — | $1,600,000.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.